A triple GLP-1R/GIPR/GCGR agonist used to investigate incretin and glucagon-receptor co-activation and energy-balance signaling.

A sterile aqueous diluent containing 0.9% benzyl alcohol for laboratory reconstitution of lyophilized research compounds.

A dual GLP-1R/GIPR agonist used to investigate incretin-receptor co-activation, insulinotropic signaling, and energy-homeostasis pathways.

A combination GHRH analog plus GHSR-1a agonist used to study synergistic GH-axis signaling and pituitary secretagogue pathways.

A four-component research blend used to study ECM remodeling, NF-κB modulation, cell-migration, and copper-dependent matrix pathways in parallel.

Dual-peptide research blend combining BPC-157 and TB-500 for studies of actin dynamics, cell migration, and angiogenic signaling pathways.

A mitochondrial-encoded 16-amino-acid peptide used to study AMPK activation, nuclear-mitochondrial retrograde signaling, and metabolic gene regulation.

A pyridine nucleotide cofactor used in research on sirtuin activity, PARP-dependent DNA-repair assays, and mitochondrial redox cycling.

A mitochondria-targeted tetrapeptide that binds cardiolipin and is used to study ETC supercomplex stability, ROS generation, and inner-membrane integrity.

A stabilized GHRH analog used to study GH-axis activation and visceral adipose metabolic signaling in experimental models.

A copper-tripeptide complex used to study extracellular-matrix gene expression, copper trafficking, and fibroblast remodeling pathways.

An ACTH(4–10) analog used to investigate BDNF/NGF upregulation, dopaminergic modulation, and neuroprotective signaling cascades.

An NNMT inhibitor used in laboratory studies of NAD+ salvage, methyl-group metabolism, and mitochondrial bioenergetics.

A long-acting amylin receptor analog used to study caloric intake signaling, gastric-emptying pathways, and incretin co-agonism in experimental systems.

A GHRH(1–29) analog used to study endogenous GH-axis stimulation and GHRH-receptor pharmacology.

A dual GHRH-analog plus GHSR-1a agonist blend used to examine synergistic GH-secretagogue signaling and IGF-1 pathway activation.

A copper-binding tripeptide used to investigate dermal matrix signaling, copper-dependent enzymatic pathways, and follicular cell models.

A combination of a GLP-1R/GIPR/GCGR triple agonist with an amylin analog for studies of dual incretin–amylin pathway modulation.

A synthetic pineal tripeptide used in research on oxidative neuronal stress, circadian peptide signaling, and neuroprotective gene-expression models.

A KISS1R agonist used to study GnRH-neuron activation and hypothalamic–pituitary–gonadal axis signaling.

A long-R3 insulin-like growth factor analog used to study IGF-1 receptor signaling, mitogenic cascades, and nutrient-partitioning models.

A 28-residue neuropeptide used to study VPAC1/VPAC2 receptor signaling, cAMP generation, and neuroimmune modulation.

A principal intracellular thiol used in research on redox homeostasis, glutathione-S-transferase activity, and oxidative-stress assays.

A synthetic tuftsin analog used to study GABAergic and anxiolytic peptide signaling, BDNF expression, and immunomodulatory pathways in vitro and in experimental models.

A multi-component research blend used to examine concurrent ECM remodeling, angiogenic signaling, and actin-cytoskeleton dynamics.

CJC-1295 is a growth hormone-releasing hormone analog that stimulates natural GH and IGF-1 production for recovery, fat loss, and anti-aging benefits.

A pentadecapeptide used in research on angiogenesis, cytoskeletal signaling (FAK–paxillin), and gastrointestinal epithelial barrier models.

A cyclic nonapeptide used to study OXTR-mediated neuroendocrine signaling, social-behavior circuits, and hypothalamic peptide transmission.

A selective MC1R agonist used in melanogenesis and melanocortin-receptor binding studies.

A SNAP-25 fragment analog used to study SNARE-complex modulation and SNARE-mediated vesicle-fusion assays.

A pan-ERR (estrogen-related receptor) agonist used to examine mitochondrial biogenesis, oxidative metabolism, and exercise-mimetic transcriptional programs.

A melanocortin-receptor agonist used to study MC3R/MC4R signaling in central melanocortin pathway assays.

A D-retro-inverso peptide used to investigate FOXO4–p53 interaction disruption and selective clearance of senescent cell populations in vitro.

A cyclic α-MSH analog used to investigate multi-subtype melanocortin-receptor agonism (MC1R, MC3R, MC4R, MC5R).

A prolonged-half-life GHRH analog used to examine sustained GH-axis stimulation in experimental systems.

A selective GHSR-1a agonist used to investigate ghrelin-receptor–mediated GH secretion with minimal off-target pituitary hormone release in research models.

A 28-residue thymic peptide used to study T-cell maturation, MHC class I expression, and innate–adaptive immune signaling.

A tetrapeptide used in studies of telomerase regulation, pineal peptide signaling, and circadian gene-expression models.